244 related articles for article (PubMed ID: 36466914)
21. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.
Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
Scand J Rheumatol; 2017 Jul; 46(4):263-272. PubMed ID: 27973968
[TBL] [Abstract][Full Text] [Related]
22. Serum Soluble Tumor Necrosis Factor Receptors 1 and 2 Are Early Prognosis Markers After ST-Segment Elevation Myocardial Infarction.
Paccalet A; Crola Da Silva C; Mechtouff L; Amaz C; Varillon Y; de Bourguignon C; Cartier R; Prieur C; Tomasevic D; Genot N; Leboube S; Derimay F; Rioufol G; Bonnefoy-Cudraz E; Mewton N; Ovize M; Bidaux G; Bochaton T
Front Pharmacol; 2021; 12():656928. PubMed ID: 34539391
[No Abstract] [Full Text] [Related]
23. Epigenome-Wide Association Study of Soluble Tumor Necrosis Factor Receptor 2 Levels in the Framingham Heart Study.
Mendelson MM; Johannes R; Liu C; Huan T; Yao C; Miao X; Murabito JM; Dupuis J; Levy D; Benjamin EJ; Lin H
Front Pharmacol; 2018; 9():207. PubMed ID: 29740313
[No Abstract] [Full Text] [Related]
24. Prognostic Role of Circulating Soluble uPAR in Various Cancers: a Systematic Review and Meta-Analysis.
Liu KL; Fan JH; Wu J
Clin Lab; 2017 May; 63(5):871-880. PubMed ID: 28627814
[TBL] [Abstract][Full Text] [Related]
25. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
26. Potential Role of Soluble TNF-α Receptors in Diagnosis of Patients with Chronic Kidney Disease.
Xun C; Zhao Y
Ann Clin Lab Sci; 2017 May; 47(3):310-314. PubMed ID: 28667032
[TBL] [Abstract][Full Text] [Related]
27. Relation of benzodiazepine use to the risk of selected cancers: breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid, and liver.
Rosenberg L; Palmer JR; Zauber AG; Warshauer ME; Strom BL; Harlap S; Shapiro S
Am J Epidemiol; 1995 Jun; 141(12):1153-60. PubMed ID: 7771453
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
29. Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis.
Zhang Q; Wang Q; Sun W; Gao F; Liu L; Cheng L; Li Z
Biomed Res Int; 2018; 2018():6124927. PubMed ID: 30596096
[TBL] [Abstract][Full Text] [Related]
30. Circulating Clusterin Levels and Cancer Risk: A Systematic Review and Meta-Analysis.
Beheshti Namdar A; Kabiri M; Mosanan Mozaffari H; Aminifar E; Mehrad-Majd H
Cancer Control; 2022; 29():10732748211038437. PubMed ID: 35465749
[TBL] [Abstract][Full Text] [Related]
31. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
[TBL] [Abstract][Full Text] [Related]
33. TNFR2 expression on non-bone marrow-derived cells is crucial for lipopolysaccharide-induced septic shock and downregulation of soluble TNFR2 level in serum.
Liu S; Rong L; Deng J; Zhao X; Liu X; Xu X; Qin Z
Cell Mol Immunol; 2011 Mar; 8(2):164-71. PubMed ID: 21258364
[TBL] [Abstract][Full Text] [Related]
34. Disordered glycemic control in women with type 2 diabetes is associated with increased TNF receptor-2 levels.
Pulido-Perez P; Torres-Rasgado E; Pérez-Fuentes R; Rosales-Encina JL; Rodríguez-Antolín J; Romero JR
J Diabetes Complications; 2021 Sep; 35(9):107974. PubMed ID: 34210601
[TBL] [Abstract][Full Text] [Related]
35. Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients.
Rathore VB; Advani SH; Nadkarni JJ
Cancer Detect Prev; 1999; 23(3):226-31. PubMed ID: 10337001
[TBL] [Abstract][Full Text] [Related]
36. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.
Kaldor JM; Day NE; Band P; Choi NW; Clarke EA; Coleman MP; Hakama M; Koch M; Langmark F; Neal FE
Int J Cancer; 1987 May; 39(5):571-85. PubMed ID: 3570550
[TBL] [Abstract][Full Text] [Related]
37. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
[TBL] [Abstract][Full Text] [Related]
38. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
39. Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.
Kouroupis D; Lanzoni G; Linetsky E; Messinger Cayetano S; Wishnek Metalonis S; Leñero C; Stone LD; Ruiz P; Correa D; Ricordi C
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4435-4438. PubMed ID: 34227081
[TBL] [Abstract][Full Text] [Related]
40. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]